May 2025 LabCoP Extended Echo Session. Closing the gap in drug-resistant TB diagnosis: the critical role of sequencing
The emergence of drug-resistant TB remains a global health threat, with only one-third of individuals estimated to have multi-drug (MDR) or rifampicin-resistant (RR) TB diagnosed a
Reaching the End TB Goals: The Role of Strong Diagnostic Networks
Each year on March 24th, World TB Day serves as an important reminder that tuberculosis (TB) remains a significant public health challenge. Despite being an ancient disease, TB con
October 2024 AMR CoP ECHO Session: The EUCAST system and EUCAST clinical breakpoints
In this Antimicrobial (AMR) Community of Practice (CoP) webinar on 11 October 2024, we focus on the European Committee on Antimicrobial Susceptibility Testing (EUCAST), tracing its
ASLM AMR CoP ECHO Session September 6 2024 : AMR through surveillance in low- and middle-income countries (LMIC) and the South African Situation
In this Antimicrobial (AMR) Community of Practice (CoP) webinar, we focuses on addressing AMR through surveillance in low- and middle-income countries (LMIC) and the South African
AMR CoP ECHO Session 12 July 2024 – The Rise of Resistance: How Bacteria Outsmart Antibiotics
In this Antimicrobial (AMR) Community of Practice (CoP) webinar, we discuss the sophisticated and crafty methods bacteria use to resist antibiotics. The session presentation is del
ASLM AMR CoP ECHO Session 28 June 2024: Utilizing Interactive GIS Platforms for Integrated Solutions in AMR, One Health, and Pandemic Preparedness
In this Antimicrobial Resistance Community of Practice (AMR CoP) webinar, we review the highlights of a groundbreaking study aimed at enhancing global antimicrobial resistance rese
AMR CoP ECHO Session 21 June 2024: Integrating One Health in EQA PT Programs: Key Considerations
In this Antimicrobial (AMR) Community of Practice (CoP) webinar, we discuss integrating One Health into external quality assurance (EQA) PT programmes and key considerations. The s